PTC Therapeutics Inc (NAS:PTCT)
$ 36.53 3.23 (9.7%) Market Cap: 2.80 Bil Enterprise Value: 2.34 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 74/100

PTC Therapeutics Inc at Jefferies Healthcare Conference Transcript

Jun 07, 2023 / 04:30PM GMT
Release Date Price: $43.58 (-3.19%)
Kelly Shi
Jefferies LLC - Analyst

Good afternoon, everyone. Thank you for attending Jefferies New York Healthcare Conference. My name is Kelly Shi, one of the biotech analysts here.

And please join me and welcome Dr. Matthew Klein, CEO; and also Ms. Kylie O'Keefe, CCO of PTC Therapeutics for this fireside chat session. And we will discuss where is the company working on at the moment, and what are the most exciting progress recently. Maybe we'll start from there, especially for the investors who're not super familiar with the company. Welcome.

Matthew Klein
PTC Therapeutics, Inc. - CEO

Sure, Kelly. Thank you so much. It's great to be here. For some background on PTC, PTC has celebrated its 25th anniversary. We are a biopharmaceutical company and discovers and develops and commercializes therapies for patients with rare disorders.

We began 25 years ago to focus on RNA biology and have grown to have several scientific platforms that are highly innovative and have yielded a number of different differentiated products. We currently have five

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot